Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and ...

Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.

In a warning letter, the Food and Drug Administration said Glenmark Pharmaceuticals failed to properly investigate flaws with a generic drug that ProPublica found was linked to U.S. deaths.

Alert FDA OKs Skytrofa for Growth Hormone Deficiency in Adults The once-weekly injection, already approved in pediatric patients with GHD, offers convenience over daily injections.